HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of Natalizumab in Intermediate Uveitis Related to Multiple Sclerosis: A Case Report.

AuthorsSégolène Roemer, Alexandre Bissig, Alda Rocca, Renaud Du Pasquier, Yan Guex-Crosier
JournalKlinische Monatsblatter fur Augenheilkunde (Klin Monbl Augenheilkd) Vol. 235 Issue 4 Pg. 476-477 (04 2018) ISSN: 1439-3999 [Electronic] Germany
Vernacular TitleWirksamkeit von Natalizumab bei intermediärer Uveitis bei Multipler Sklerose: ein Fallbericht.
PMID29452449 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Natalizumab
Topics
  • Adult
  • Antibodies, Monoclonal
  • Female
  • Humans
  • Multiple Sclerosis
  • Natalizumab (therapeutic use)
  • Treatment Outcome
  • Uveitis, Intermediate (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: